Zhang Ning, Zhai Liting, Wong Ronald Man Yeung, Cui Can, Law Sheung-Wai, Chow Simon Kwoon-Ho, Goodman Stuart B, Cheung Wing-Hoi
Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong, China.
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Immun Ageing. 2024 Aug 5;21(1):55. doi: 10.1186/s12979-024-00458-9.
Sarcopenia is a complex age-associated syndrome of progressive loss of muscle mass and strength. Although this condition is influenced by many factors, age-related changes in immune function including immune cell dynamics, and chronic inflammation contribute to its progression. The complex interplay between the immune system, gut-muscle axis, and autophagy further underscores their important roles in sarcopenia pathogenesis. Immunomodulation has emerged as a promising strategy to counteract sarcopenia. Traditional management approaches to treat sarcopenia including physical exercise and nutritional supplementation, and the emerging technologies of biophysical stimulation demonstrated the importance of immunomodulation and regulation of macrophages and T cells and reduction of chronic inflammation. Treatments to alleviate low-grade inflammation in older adults by modulating gut microbial composition and diversity further combat sarcopenia. Furthermore, some pharmacological interventions, nano-medicine, and cell therapies targeting muscle, gut microbiota, or autophagy present additional avenues for immunomodulation in sarcopenia. This narrative review explores the immunological underpinnings of sarcopenia, elucidating the relationship between the immune system and muscle during ageing. Additionally, the review discusses new areas such as the gut-muscle axis and autophagy, which bridge immune system function and muscle health. Insights into current and potential approaches for sarcopenia management through modulation of the immune system are provided, along with suggestions for future research directions and therapeutic strategies. We aim to guide further investigation into clinical immunological biomarkers and identify indicators for sarcopenia diagnosis and potential treatment targets to combat this condition. We also aim to draw attention to the importance of considering immunomodulation in the clinical management of sarcopenia.
肌肉减少症是一种与年龄相关的复杂综合征,表现为肌肉质量和力量的进行性丧失。尽管这种病症受多种因素影响,但免疫功能的年龄相关变化,包括免疫细胞动态变化和慢性炎症,都促使其发展。免疫系统、肠道 - 肌肉轴和自噬之间的复杂相互作用进一步突显了它们在肌肉减少症发病机制中的重要作用。免疫调节已成为对抗肌肉减少症的一种有前景的策略。治疗肌肉减少症的传统管理方法,包括体育锻炼和营养补充,以及新兴的生物物理刺激技术,都证明了免疫调节以及调节巨噬细胞和T细胞并减轻慢性炎症的重要性。通过调节肠道微生物组成和多样性来减轻老年人低度炎症的治疗方法,进一步对抗肌肉减少症。此外,一些针对肌肉、肠道微生物群或自噬的药物干预、纳米医学和细胞疗法,为肌肉减少症的免疫调节提供了更多途径。这篇叙述性综述探讨了肌肉减少症的免疫学基础,阐明了衰老过程中免疫系统与肌肉之间的关系。此外,该综述还讨论了肠道 - 肌肉轴和自噬等新领域,这些领域连接了免疫系统功能和肌肉健康。本文提供了对通过调节免疫系统管理肌肉减少症的当前和潜在方法的见解,以及对未来研究方向和治疗策略的建议。我们旨在指导对临床免疫学生物标志物的进一步研究,并确定肌肉减少症诊断指标和潜在治疗靶点,以对抗这种病症。我们还旨在提请人们注意在肌肉减少症临床管理中考虑免疫调节的重要性。